How serious is Klebsiella pneumoniae UTI

How serious is Klebsiella pneumoniae UTI

Toxic presentation with sudden onset, high fever, and hemoptysis (currant jelly sputum).Pneumoniae appear to be increasing and have become a real health problem, especially in hospital settings.The overall mortality rate associated with this infection was 20%, with over one half of all deaths occurring in infants who were afebrile at the time bacteremia was documented.Clinical features include frequency, urgency, dysuria, hesitancy, low back pain, and suprapubic.Klebsiella pneumoniae may cause infections such as pneumonia, meningitis, and liver abscess.

Estimated number of people with this diseaseIt also causes necrotizing pneumonia, pyogenic liver abscesses and endogenous endophthalmitis [3].For example, your surgical wound could be infected.People with a compromised immune system and/or people who have an implanted medical device (such as a urinary catheter or airway tube) are more at risk for klebsiella infections.Klebsiella pneumoniae may make its way to other parts of your body, causing various infections like pneumonia and urinary tract infections — or utis.

You could also get an infection in your:According to shiri et al.Ko can also lead to urinary tract infections (utis), wound infections, and more.28 for nosocomial infections, nontypeable isolates were predominant when the source of infection was identified as the lung, the urinary tract, or an unknown source.A uti can affect any part of the urinary system, including the urethra, kidneys, bladder, and ureters.

25 Related Question Answers Found

Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns

Superbugs: Finding the path of least resistance

Widespread antibiotic resistance to bacterial infections confirmed in WHO global testing

Bacteria antibiotic resistance is winning the day and a major threat to public health

Results at Seven Years After the Use of Intracamerular Cefazolin as an Endophthalmitis Prophylaxis in Cataract Surgery

Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States

One Health drivers of antibacterial resistance in Thailand

Pittet Lab

Contrafect Reports First Quarter 2022 Financial Results And Provides Business Update

Immunology Institute fosters collaboration to harness the power of the immune system to fight disease

Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States